DaVita Inc.

DVA Healthcare Medical Care Facilities

DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024. In the quarter to June 2026, revenue grew 5.17%, EPS grew 56.5%, free cash flow grew 49.4% and total debt rose 4.40%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

187.31 1.85 −0.98%
Market cap
$12.1B
P/E
15.0×
Fwd P/E
13.1×
Dividend yield
—
F-score
6/9
Altman Z
1.49
Beneish M
−2.59
Dividend safety
n/a

DaVita Inc. (DVA) EBITDA

Alert me on EBITDA

DaVita Inc.'s EBITDA for fiscal 2025 was $2.8B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $2.8B. Over the past ten years it has ranged from $1.8B (fiscal 2015) to $2.8B (fiscal 2024); the current reading is higher than 91% of that period. DaVita Inc. ranks 4th of 52 Medical Care Facilities companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $2.8B (1.97%)
FY2024 $2.8B 19.85%
FY2023 $2.3B 13.35%
FY2022 $2.1B (16.40%)
FY2021 $2.5B 6.58%
FY2020 $2.3B 2.95%
FY2019 $2.3B 6.69%
FY2018 $2.1B (18.28%)
FY2017 $2.6B (5.81%)
FY2016 $2.7B 54.95%

Quarterly newest first

Period EBITDA Change
Jun 2026 $746.8M 13.20%
Mar 2026 $659.7M (11.78%)
Dec 2025 $747.8M 9.44%
Sep 2025 $683.3M (4.11%)
42 more quarters

Against its own ten years

Low $1.8B High $2.8B
Ten-year median $2.3B
Current reading's percentile 91

EBITDA against peers

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on DVA